rxstat › Drug prices › Palbociclib

Palbociclib (Ibrance) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Nov 16, 2026

Palbociclib 100 mg tablet costs about $126.96 to $138.38 per tablet on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee. The brand (Ibrance) lists at $276.76.

Palbociclib has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABONNBNSPENL
100 mg Tabletper tablet$215.83not covered$126.96brand $253.91$126.96$126.96$126.96$138.38brand $276.76
125 mg Tabletper tablet$215.83not covered$126.96brand $253.91$126.96$126.96$126.96$138.38brand $276.76
75 mg Tabletper tablet$215.83not covered$126.96brand $253.91$126.96$126.96$126.96$138.38brand $276.76
Plan coverageNot coveredCoveredSpecial approvalSpecial approvalPrice listPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay. In Ontario, the plan pays only up to the lowest interchangeable price ($126.96 per tablet for 75 mg).

Listed products by province

Alberta: 9 products
  • Pms-Palbociclib 100 mg Tablet · PMS
    DIN 02552132 · $215.83/tablet · Not covered
  • Pms-Palbociclib 125 mg Tablet · PMS
    DIN 02552140 · $215.83/tablet · Not covered
  • Pms-Palbociclib 75 mg Tablet · PMS
    DIN 02552124 · $215.83/tablet · Not covered
  • Taro-Palbociclib 100 mg Tablet · TAR
    DIN 02547643 · $215.83/tablet · Not covered
  • Taro-Palbociclib 125 mg Tablet · TAR
    DIN 02547651 · $215.83/tablet · Not covered
  • Taro-Palbociclib 75 mg Tablet · TAR
    DIN 02547635 · $215.83/tablet · Not covered
  • Ibrance 100 mg Tablet · PFI
    DIN 02493543 · $253.91/tablet · Not covered
  • Ibrance 125 mg Tablet · PFI
    DIN 02493551 · $253.91/tablet · Not covered
  • Ibrance 75 mg Tablet · PFI
    DIN 02493535 · $253.91/tablet · Not covered
Ontario: 9 products
  • Taro-Palbociclib 75 mg Tablet · Taro Pharmaceuticals Inc.
    DIN 02547635 · $126.96/tablet · Covered
  • Pms-Palbociclib 75 mg Tablet · Pharmascience Inc.
    DIN 02552124 · $126.96/tablet · Covered
  • Taro-Palbociclib 100 mg Tablet · Taro Pharmaceuticals Inc.
    DIN 02547643 · $126.96/tablet · Covered
  • Pms-Palbociclib 100 mg Tablet · Pharmascience Inc.
    DIN 02552132 · $126.96/tablet · Covered
  • Taro-Palbociclib 125 mg Tablet · Taro Pharmaceuticals Inc.
    DIN 02547651 · $126.96/tablet · Covered
  • Pms-Palbociclib 125 mg Tablet · Pharmascience Inc.
    DIN 02552140 · $126.96/tablet · Covered
  • Ibrance 75 mg Tablet · Pfizer Canada Inc.
    DIN 02493535 · $253.91/tablet · Covered
  • Ibrance 100 mg Tablet · Pfizer Canada Inc.
    DIN 02493543 · $253.91/tablet · Covered
  • Ibrance 125 mg Tablet · Pfizer Canada Inc.
    DIN 02493551 · $253.91/tablet · Covered
New Brunswick: 9 products
  • Ibrance 75 mg Tablet · PFI
    DIN 02493535 · $126.96/tablet · Special approval
  • Ibrance 100 mg Tablet · PFI
    DIN 02493543 · $126.96/tablet · Special approval
  • Ibrance 125 mg Tablet · PFI
    DIN 02493551 · $126.96/tablet · Special approval
  • Taro-Palbociclib 75 mg Tablet · TAR
    DIN 02547635 · $126.96/tablet · Special approval
  • Taro-Palbociclib 100 mg Tablet · TAR
    DIN 02547643 · $126.96/tablet · Special approval
  • Taro-Palbociclib 125 mg Tablet · TAR
    DIN 02547651 · $126.96/tablet · Special approval
  • Pms-Palbociclib 75 mg Tablet · PMS
    DIN 02552124 · $126.96/tablet · Special approval
  • Pms-Palbociclib 100 mg Tablet · PMS
    DIN 02552132 · $126.96/tablet · Special approval
  • Pms-Palbociclib 125 mg Tablet · PMS
    DIN 02552140 · $126.96/tablet · Special approval
Nova Scotia: 9 products
  • Ibrance 100 mg Tablet · PFI
    DIN 02493543 · $126.96/tablet · Special approval
  • Taro-Palbociclib 100 mg Tablet · TAR
    DIN 02547643 · $126.96/tablet · Special approval
  • Pms-Palbociclib 100 mg Tablet · PMS
    DIN 02552132 · $126.96/tablet · Special approval
  • Ibrance 125 mg Tablet · PFI
    DIN 02493551 · $126.96/tablet · Special approval
  • Taro-Palbociclib 125 mg Tablet · TAR
    DIN 02547651 · $126.96/tablet · Special approval
  • Pms-Palbociclib 125 mg Tablet · PMS
    DIN 02552140 · $126.96/tablet · Special approval
  • Ibrance 75 mg Tablet · PFI
    DIN 02493535 · $126.96/tablet · Special approval
  • Taro-Palbociclib 75 mg Tablet · TAR
    DIN 02547635 · $126.96/tablet · Special approval
  • Pms-Palbociclib 75 mg Tablet · PMS
    DIN 02552124 · $126.96/tablet · Special approval
Prince Edward Island: 9 products
  • Ibrance 75 mg Tablet · PFI
    DIN 02493535 · $126.96/tablet · Price list
  • Taro-Palbociclib 75 mg Tablet · TAR
    DIN 02547635 · $126.96/tablet · Price list
  • Pms-Palbociclib 75 mg Tablet · PMS
    DIN 02552124 · $126.96/tablet · Price list
  • Ibrance 100 mg Tablet · PFI
    DIN 02493543 · $126.96/tablet · Price list
  • Taro-Palbociclib 100 mg Tablet · TAR
    DIN 02547643 · $126.96/tablet · Price list
  • Pms-Palbociclib 100 mg Tablet · PMS
    DIN 02552132 · $126.96/tablet · Price list
  • Ibrance 125 mg Tablet · PFI
    DIN 02493551 · $126.96/tablet · Price list
  • Taro-Palbociclib 125 mg Tablet · TAR
    DIN 02547651 · $126.96/tablet · Price list
  • Pms-Palbociclib 125 mg Tablet · PMS
    DIN 02552140 · $126.96/tablet · Price list
Newfoundland and Labrador: 9 products
  • Pms-Palbociclib 75 mg Tablet · PMS
    DIN 02552124 · $138.38/tablet · Price list
  • Taro-Palbociclib 75 mg Tablet · TPT
    DIN 02547635 · $138.38/tablet · Price list
  • Pms-Palbociclib 100 mg Tablet · PMS
    DIN 02552132 · $138.38/tablet · Price list
  • Taro-Palbociclib 100 mg Tablet · TPT
    DIN 02547643 · $138.38/tablet · Price list
  • Pms-Palbociclib 125 mg Tablet · PMS
    DIN 02552140 · $138.38/tablet · Price list
  • Taro-Palbociclib 125 mg Tablet · TPT
    DIN 02547651 · $138.38/tablet · Price list
  • Ibrance 75 mg Tablet · PFI
    DIN 02493535 · $276.76/tablet · Price list
  • Ibrance 100 mg Tablet · PFI
    DIN 02493543 · $276.76/tablet · Price list
  • Ibrance 125 mg Tablet · PFI
    DIN 02493551 · $276.76/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · PEI Pharmacare Maximum Reimbursable Price List (Nov 24, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

No shortage or discontinuation reports have been filed with Health Canada for Palbociclib. rxstat watches those reports through the day; sign up below to hear if that changes.

Common questions

How much does Palbociclib cost in Canada?

Palbociclib 100 mg tablet costs about $126.96 to $138.38 per tablet on public drug plan price lists across 5 provinces, before the pharmacy's dispensing fee. The brand (Ibrance) lists at $276.76.

Is Palbociclib covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval; Prince Edward Island: price list; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.